Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Testosterone propionate
Drug ID BADD_D02173
Description Testosterone propionate is a slower-releasing anabolic steroid with a short half-life. It is a synthetic androstane steroid derivative of testosterone in the form of 17β propionate ester of testosterone.[T83] Testosterone propionate was developed initially by Watson labs, and FDA approved on February 5, 1974. Currently, this drug has been discontinued in humans, but the vet application is still available as an OTC.[L1160]
Indications and Usage Testosterone propionate is often used for muscle mass building. The original medical indication is for the treatment of androgen deficiency in male adults either in hypogonadism or andropause.[L1161] Nowadays testosterone propionate is indicated for its use in heifers in order to stimulate maximal growth.[L1160]
Marketing Status Discontinued
ATC Code G03BA03
DrugBank ID DB01420
KEGG ID D00959
MeSH ID D043343
PubChem ID 5995
TTD Drug ID Not Available
NDC Product Code 22552-0015; 52128-172; 64025-0019; 48087-0134; 51552-0030; 60870-0253; 30007-833; 62991-1412; 38779-0165; 0009-5123; 43647-789; 51927-1029; 49452-0011
Synonyms Testosterone Propionate | Testosteron Propionat Eifelfango | Eifelfango, Testosteron Propionat | Virormone | Agovirin
Chemical Information
Molecular Formula C22H32O3
CAS Registry Number 57-85-2
SMILES CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Glucose tolerance impaired14.06.02.001; 05.06.02.001--
Growth accelerated15.03.01.001; 05.03.01.001--
Gynaecomastia21.05.04.003; 05.05.02.003--
Haematuria24.07.01.047; 20.02.01.006--
Haemoglobin13.01.05.018--Not Available
Headache17.14.01.001--
Hepatic neoplasm16.07.03.001; 09.04.03.001--Not Available
Hirsutism23.02.04.001; 05.05.01.005--
Hypercholesterolaemia14.08.01.001--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Immune system disorder10.02.01.001--Not Available
Incontinence20.02.02.004; 17.05.01.006; 07.01.06.011--Not Available
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Irritability19.04.02.013; 08.01.03.011--
Jaundice cholestatic09.01.01.005--Not Available
Libido decreased19.08.03.001; 21.03.02.005--
Liver function test abnormal13.03.01.013--Not Available
Malaise08.01.01.003--
Myalgia15.05.02.001--
Nausea07.01.07.001--
Neoplasm16.16.02.001--Not Available
Nervous system disorder17.02.10.001--Not Available
Oedema08.01.07.006; 14.05.06.010--Not Available
Oligospermia21.03.03.005--
Pain08.01.08.004--
Paraesthesia17.02.06.005--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages